Literature DB >> 1496620

Significance of a positive crossmatch on outcome in human liver transplantation.

K Ogura1, H Koyama, S Takemoto, P I Terasaki, R W Busuttil.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1496620

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant.

Authors:  J G O'Leary; H Kaneku; B M Susskind; L W Jennings; M A Neri; G L Davis; G B Klintmalm; P I Terasaki
Journal:  Am J Transplant       Date:  2011-06-14       Impact factor: 8.086

2.  Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch.

Authors:  H R Doyle; I R Marino; F Morelli; C Doria; L Aldrighetti; J McMichael; J Martell; T Gayowski; T E Starzl
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

3.  Class II alloantibody and mortality in simultaneous liver-kidney transplantation.

Authors:  J G O'Leary; H M Gebel; R Ruiz; R A Bray; J D Marr; X J Zhou; S M Shiller; B M Susskind; A D Kirk; G B Klintmalm
Journal:  Am J Transplant       Date:  2013-02-22       Impact factor: 8.086

Review 4.  What's new in clinical solid organ transplantation by 2013.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2014-12-24

5.  Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.

Authors:  Jacqueline G O'Leary; Hugo Kaneku; Anthony J Demetris; John D Marr; S Michelle Shiller; Brian M Susskind; Glenn W Tillery; Paul I Terasaki; Göran B Klintmalm
Journal:  Liver Transpl       Date:  2014-01-02       Impact factor: 5.799

6.  Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance.

Authors:  R Mañez; R H Kelly; M Kobayashi; S Takaya; O Bronsther; D Kramer; R J Duquesnoy; Y Iwaki; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

7.  De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.

Authors:  H Kaneku; J G O'Leary; N Banuelos; L W Jennings; B M Susskind; G B Klintmalm; P I Terasaki
Journal:  Am J Transplant       Date:  2013-06       Impact factor: 8.086
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.